Clinical observation of glucocorticoid therapy for critically ill patients with COVID-19 pneumonia
Objective We aimed to investigate the clinical effects of intravenous glucocorticoid (GC) therapy for severe COVID-19 pneumonia. Methods Seventy-two patients hospitalized with severe COVID-19 pneumonia who were discharged or died between 5 January 2020 and 3 March 2020 at Huangshi Infectious Disease...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2023-02-01
|
Series: | Journal of International Medical Research |
Online Access: | https://doi.org/10.1177/03000605221149292 |